SHARE

Dr. Martens sees early gains from consumer-first strategy as Americas drive revenue growth

Dr. Martens reported group revenue up 0.8% to £322m for the first half, led by 6% growth in the Americas. The footwear brand narrowed its adjusted pre-tax loss to £9.2m, citing improved product mix and cost management.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.